Vincristine Sulphate Injection bulk supplier for pharma manufacturers

Vincristine Sulphate Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 1 mg/10 mL (0.1 mg/mL), 2 mg/10 mL (0.2 mg/mL)

Reference Brands: Oncovin®(US)

Vincristine Sulphate Injection is a chemotherapy drug used to treat cancers like leukemia, lymphoma, and neuroblastoma. Available in the US as Oncovin® and in the EU under various brands like Vincristine Ebewe, it works by inhibiting cell division. Ideal for B2B pharmaceutical companies seeking to enhance their oncology portfolio.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Vincristine Sulphate Injection? List it or send an offer →

Product Description: Vincristine Sulphate Injection is a chemotherapy medication used in the treatment of various cancers, including leukemia, lymphoma, neuroblastoma, and Wilms tumor. As a mitotic inhibitor, vincristine works by disrupting cell division, preventing cancer cells from growing and multiplying. In the US, it is marketed under the brand name Oncovin® and is available in various strengths for intravenous administration. In the EU, it is marketed under several brand names, including Vincristine Ebewe. Ideal for B2B pharmaceutical companies looking to expand their oncology product portfolio, this injection is crucial for combination therapy in cancer management globally.

Vincristine Sulphate Injection — third party manufacturing & bulk supply

Vincristine Sulphate Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Vincristine Sulphate Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Vincristine Sulphate Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Vincristine Sulphate Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Vincristine Sulphate Injection is listed as Injection in 1 mg/10 mL (0.1 mg/mL), 2 mg/10 mL (0.2 mg/mL). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Vincristine Sulphate Injection is referenced against Oncovin®(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.